| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.03 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.03 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |